Partner notification outcomes
During all phases of the pilot a total of 25 (3.2%; n = 783) patients were diagnosed positive for a STI (24 for chlamydia and one for genital herpes) across eight practices. They are summarised in . The majority of patients (n = 18) came through patient referral practices, five through provider and two through contract (–). The majority of patients diagnosed with a STI were female (22 females vs. 3 males). The HA was able to contact successfully 11 (44%) of the patients diagnosed with a STI, six (24%) of whom were followed up at 1 week and two (8%) subsequently followed up at the 6-week and 3-month periods.
Follow-up of positive respondents.
Consent at diagnosis practices recruited in phase 1 and continuing (n = 3) (8 November 2010–31 July 2012).
Intensive recruitment practices recruited in phase 4 (n = 8) (2 February 2012–3 August 2012).
Consent at test practices recruited in phase 1 and continuing (n = 3) (November 2010–31 July 2012).
Consent at test practices newly recruited in phase 3 and continuing (n = 2) (11 July 2011–31 July 2012).
Partners were known to have been tested for four patients; three partners were diagnosed positive for chlamydia and for two of these the HA was told by the index patient that they had been treated. The two participants who were followed up at the 3-month period were retested for chlamydia, with both testing negative.
Given the small numbers, it is not possible to present outcome data for the range of primary and secondary outcomes.
Consolidated Standards of Reporting Trials diagrams
Summary recruitment data have been given at the end of each chapter describing a pilot phase, with a complete summary at the end of phase 4. Here we present for completeness the Consolidated Standards of Reporting Trials (CONSORT) flow diagrams for the various phases and categories of practice (–).
Consent at diagnosis practice recruited in phase 4 (n = 1) (3 February 2012–31 July 2012).
